$2.3 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 141 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| K | KELLOGG COcall | $19,632,000 | +6.2% | 300,000 | 0.0% | 0.85% | +2.8% | |
| KOS | KOSMOS ENERGY LTD | $5,454,000 | -15.8% | 650,000 | 0.0% | 0.24% | -18.6% | |
| DMND | DIAMOND FOODS INC | $4,685,000 | -1.3% | 165,969 | 0.0% | 0.20% | -4.2% | |
| XOMA | XOMA CORP DELcall | $3,267,000 | -14.7% | 910,000 | 0.0% | 0.14% | -17.4% | |
| ATRS | ANTARES PHARMA INC | $2,996,000 | +40.5% | 1,165,738 | 0.0% | 0.13% | +35.4% | |
| PAH | PLATFORM SPECIALTY PRODUCTS CORP | $2,006,000 | -7.2% | 86,373 | 0.0% | 0.09% | -10.3% | |
| TLOG | TETRALOGIC PHARMACEUTICALS C | $1,382,000 | +17.8% | 286,801 | 0.0% | 0.06% | +13.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 30 | Q4 2023 | 34.8% |
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| ISHARES TR | 29 | Q2 2024 | 13.2% |
| SOL GEL TECHNOLOGIES | 26 | Q2 2024 | 1.5% |
| META PLATFORMS INC | 25 | Q2 2024 | 5.9% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| BEYOND AIR INC | 20 | Q2 2024 | 1.7% |
| AMAZON COM INC | 19 | Q2 2024 | 7.6% |
| SALESFORCE INC | 19 | Q1 2024 | 3.2% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CURIS INC | April 15, 2024 | 345,730 | 5.9% |
| Applied Minerals, Inc. | February 06, 2024 | 21,265,377 | 5.0% |
| Praxis Precision Medicines, Inc. | February 06, 2024 | 346,665 | 2.9% |
| SCYNEXIS INC | November 29, 2023 | 2,237,048 | 6.0% |
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-21 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.